Literature DB >> 14661688

Principles of drug therapy for the elderly patient.

Rubin Bressler1, Joseph J Bahl.   

Abstract

Physicians will treat larger numbers of elderly patients as the US population ages. Being treated simultaneously for more than 1 condition with multiple prescription drugs is only 1 reason why elderly patients are at greater risk of experiencing adverse drug reactions. The need for physicians to minimize the incidence of these reactions has become incumbent on both physicians and administrators. We review the underlying reasons why the elderly population is at risk of adverse drug reactions and summarize the principles of drug-drug interaction, metabolism, and distribution, which can help elderly patients receive proper pharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661688     DOI: 10.4065/78.12.1564

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  44 in total

Review 1.  Treatment of type 2 diabetes in the elderly.

Authors:  Medha N Munshi; Megumi Maguchi; Alissa R Segal
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

2.  Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial.

Authors:  Benoit Cossette; Jean-François Éthier; Thomas Joly-Mischlich; Josée Bergeron; Geneviève Ricard; Serge Brazeau; Mathieu Caron; Olivier Germain; Hélène Payette; Janusz Kaczorowski; Mitchell Levine
Journal:  Eur J Clin Pharmacol       Date:  2017-07-17       Impact factor: 2.953

Review 3.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

4.  Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change.

Authors:  Angelica P Herrera; Shedra Amy Snipes; Denae W King; Isabel Torres-Vigil; Daniel S Goldberg; Armin D Weinberg
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

5.  Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.

Authors:  Alessandro Nobili; Giuseppe Licata; Francesco Salerno; Luca Pasina; Mauro Tettamanti; Carlotta Franchi; Luigi De Vittorio; Alessandra Marengoni; Salvatore Corrao; Alfonso Iorio; Maura Marcucci; Pier Mannuccio Mannucci
Journal:  Eur J Clin Pharmacol       Date:  2011-01-11       Impact factor: 2.953

Review 6.  Identification and management of in-hospital drug-induced delirium in older patients.

Authors:  Angela G Catic
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

7.  Innovative collaborative practice to optimize pharmacotherapy for frail older patients.

Authors:  Shanna Trenaman; Susan K Bowles; Laurie Mallery; Katalin Koller; Melissa Andrew
Journal:  Can J Hosp Pharm       Date:  2014-09

8.  Post mortem toxicology in the elderly.

Authors:  Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2012-12-07       Impact factor: 2.007

Review 9.  HIV infection in the elderly.

Authors:  Nancy Nguyen; Mark Holodniy
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  Not Geropharmacotherapy 101.

Authors:  Albert J Finestone; Michael R Jacobs; John A Cacciamani
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.